INTESTINAL DIALYSIS Trademark

Trademark Overview

On Tuesday, November 30, 2021, a trademark application was filed for INTESTINAL DIALYSIS with the United States Patent and Trademark Office. The USPTO has given the INTESTINAL DIALYSIS trademark a serial number of 97148493. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by KIBOW BIOTECH, INC.. The INTESTINAL DIALYSIS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Retail store services featuring nutritional supplements containing probiotics and prebiotics which eliminate uremic toxins in the body
intestinal dialysis

General Information

Serial Number97148493
Word MarkINTESTINAL DIALYSIS
Filing DateTuesday, November 30, 2021
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7264400
Registration DateTuesday, January 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesRetail store services featuring nutritional supplements containing probiotics and prebiotics which eliminate uremic toxins in the body

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 23, 2023
Primary Code035
First Use Anywhere DateFriday, January 24, 2020
First Use In Commerce DateFriday, January 24, 2020

Trademark Owner History

Party NameKIBOW BIOTECH LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressEXTON, PA 19341
Party NameKIBOW BIOTECH, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19073
Party NameKIBOW BIOTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19073

Trademark Events

Event DateEvent Description
Friday, December 3, 2021NEW APPLICATION ENTERED
Friday, December 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 9, 2022ASSIGNED TO EXAMINER
Friday, September 16, 2022NON-FINAL ACTION WRITTEN
Friday, September 16, 2022NON-FINAL ACTION E-MAILED
Friday, September 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 24, 2023NON-FINAL ACTION WRITTEN
Friday, March 24, 2023NON-FINAL ACTION E-MAILED
Friday, March 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 23, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 23, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 23, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, May 23, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 10, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 2, 2024REGISTERED-SUPPLEMENTAL REGISTER

Related Keywords

dialysis intestinal which prebiotics eliminate uremic body toxins probiotics containing services store